PDF(Pubmed)
Abstract：
Endoscopic submucosal dissection (ESD) is a transformative advancement in the endoscopic management of superficial gastrointestinal lesions. Initially conceived for the treatment of early gastric cancer, ESD has demonstrated proficiency in achieving en-bloc resection of superficial gastrointestinal lesions. ESD has experienced widespread acceptance in Japan and East Asia; however, its adoption in the USA remains delayed. This initial hesitancy could be attributed to procedural complexity and training demands; nonetheless, recently, ESD has been gaining popularity in the USA. This is due to the advancements in endoscopic technology, tailored training programs, and cumulative evidence regarding the efficacy and safety of ESDs. This review aimed to deliberate the historical progress, current implementation, and prospective trajectory of ESDs in the USA. With ongoing clinical research, technological integration, and educational efforts, ESD is likely to become the gold standard for managing large gastrointesitinal lesions. This progress marks an imperative step toward less invasive, more precise, and patient-centric approaches regarding advanced therapeutic endoscopy in the USA.
摘要：
内镜粘膜下剥离术（ESD）是内镜治疗浅表胃肠道病变的革命性进展。最初设想用于治疗早期胃癌，ESD已证明在实现浅表胃肠道病变的整块切除方面具有熟练的能力。可持续发展教育在日本和东亚得到广泛接受；然而，它在美国的采用仍然被推迟。这种最初的犹豫可以归因于程序的复杂性和培训需求；尽管如此，最近,ESD在美国越来越受欢迎。这是由于内窥镜技术的进步，量身定制的培训计划，以及有关ESD疗效和安全性的累积证据。这次回顾旨在探讨历史进步，当前实施，以及美国ESD的预期轨迹。随着临床研究的进行,技术集成,和教育努力，ESD可能成为治疗大胃肠病损的金标准。这一进展标志着朝着减少侵入性迈出了必要的一步，更精确,和以患者为中心的方法在美国先进的治疗性内窥镜检查。
